APA (7th ed.) Citation

Meagher, M., Minervini, A., Mir, M. C., Cerrato, C., Rebez, G., Autorino, R., . . . Derweesh, I. H. (2024). Does the timing of cytoreductive nephrectomy impact outcomes?: Analysis of REMARCC registry data for patients receiving tyrosine kinase inhibitor versus immune checkpoint inhibitor therapy. European urology open science, 63, . https://doi.org/10.1016/j.euros.2024.02.001

Chicago Style (17th ed.) Citation

Meagher, Margaret, et al. "Does the Timing of Cytoreductive Nephrectomy Impact Outcomes?: Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy." European Urology Open Science 63 (2024). https://doi.org/10.1016/j.euros.2024.02.001.

MLA (9th ed.) Citation

Meagher, Margaret, et al. "Does the Timing of Cytoreductive Nephrectomy Impact Outcomes?: Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy." European Urology Open Science, vol. 63, 2024, https://doi.org/10.1016/j.euros.2024.02.001.